My only point was if one is to believe Vertex Boceprevir is a very inferior Protease Inhibitor. In my opinion as a potential drug I would have Boceprevir ahead of 191 but if things play out how Vertex was implying Boceprevir may be a commercial flop.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.